Original Article
Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment
Müge Olgaça,
, Osman Ozan Yeğitb, Şengül Beyazb, Nida Öztopb, Can Tüzerb, Deniz Eyiceb, Pelin Karadağb, Raif Coşkunc, Semra Demirb, Bahaauddin Çolakoğlub, Suna Büyüköztürkb, Aslı Gelincikb
a Division of Immunology and Allergic Diseases, Şişli Hamidiye Etfal Research and Education Hospital, Istanbul, Turkey
b Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
c Division of Immunology and Allergic Diseases, Okmeydanı Research and Education Hospital, Istanbul, Turkey
Lido
7147
Vezesque se leu este artigo
2405
Total PDF
4742
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 10 | 200 | 105 | 305 |
| 2025 9 | 213 | 83 | 296 |
| 2025 8 | 185 | 88 | 273 |
| 2025 7 | 220 | 78 | 298 |
| 2025 6 | 207 | 66 | 273 |
| 2025 5 | 213 | 64 | 277 |
| 2025 4 | 163 | 45 | 208 |
| 2025 3 | 193 | 50 | 243 |
| 2025 2 | 220 | 86 | 306 |
| 2025 1 | 151 | 70 | 221 |
| 2024 12 | 125 | 65 | 190 |
| 2024 11 | 133 | 46 | 179 |
| 2024 10 | 140 | 81 | 221 |
| 2024 9 | 168 | 88 | 256 |
| 2024 8 | 207 | 125 | 332 |
| 2024 7 | 167 | 103 | 270 |
| 2024 6 | 156 | 97 | 253 |
| 2024 5 | 125 | 53 | 178 |
| 2024 4 | 154 | 88 | 242 |
| 2024 3 | 136 | 76 | 212 |
| 2024 2 | 153 | 84 | 237 |
| 2024 1 | 93 | 66 | 159 |
| 2023 12 | 87 | 65 | 152 |
| 2023 11 | 82 | 92 | 174 |
| 2023 10 | 66 | 86 | 152 |
| 2023 9 | 88 | 80 | 168 |
| 2023 8 | 60 | 35 | 95 |
| 2023 7 | 71 | 37 | 108 |
| 2023 6 | 67 | 50 | 117 |
| 2023 5 | 92 | 32 | 124 |
| 2023 4 | 89 | 51 | 140 |
| 2023 3 | 147 | 68 | 215 |
| 2023 2 | 124 | 51 | 175 |
| 2023 1 | 47 | 51 | 98 |
Mostrar tudo
